Alopecia in Patients Treated with Molecularly Targeted Anticancer Therapies

September 2015 in “ Annals of Oncology ”

Viswanath Reddy Belum, Kathleen Marulanda, Courtney J. Ensslin, Loren Gorcey, Tapan Parikh, S. Wu, Klaus J. Busam, Peter Arne Gerber, Mario E. Lacouture

alopecia molecularly targeted anticancer therapies bortezomib vismodegib chemotherapy hair abnormalities textural changes dyspigmentation

Studysummary This study reported that targeted anticancer therapies are associated with an increased risk of alopecia compared to placebo, although the risk was lower compared to chemotherapy.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

View this study on annalsofoncology.org →

Discuss this study in the Community →

Research cited in this study

12 / 12 results

research A Hospital-Based Study to Determine Causes of Diffuse Hair Loss in Women

19 citations , January 2015 in “Journal of Clinical and Diagnostic Research”

This study found that telogen effluvium was the most common type of diffuse hair loss among women, with psychological stress and iron deficiency anemia being significant contributing factors.

research Pathobiology of Chemotherapy-Induced Hair Loss

218 citations , January 2013 in “The Lancet Oncology”

This review discusses the pathobiology of chemotherapy-induced alopecia and highlights challenges in managing it, reporting no new clinical results and emphasizing the need for well-designed preclinical models to develop effective treatments.

research Androgenetic Alopecia in Policemen: Higher Prevalence and Different Risk Factors Relative to the General Population (KCIS No. 23)

12 citations , September 2011 in “Archives of Dermatological Research”

This study found that policemen aged 40-59 years had a twofold higher prevalence of androgenetic alopecia compared to the general population, with obesity and sunlight exposure contributing to the risk.

research Scarring Alopecia Associated With the Epidermal Growth Factor Receptor Inhibitor Erlotinib

32 citations , April 2011 in “Journal of the American Academy of Dermatology”

Erlotinib may cause scarring hair loss.

research Cetuximab-Associated Elongation of the Eyelashes

30 citations , August 2010 in “American Journal of Clinical Dermatology”

This article reviews eyelash elongation as a side effect of EGFR inhibitors in cancer treatment, finding that the condition is typically not severe and may be managed by trimming.

research Folliculitis Decalvans Associated with Erlotinib

25 citations , April 2010 in “Clinical and Experimental Dermatology”

Erlotinib can cause hair loss and scalp issues, which improve after stopping the drug.

research Chemotherapy-Induced Alopecia: Emotional Distress and Mitigation Strategies

155 citations , March 2009 in “Seminars in Cutaneous Medicine and Surgery”

This review covers various strategies to manage chemotherapy-induced alopecia, highlighting that agents like AS101 and minoxidil can reduce its severity but not prevent it, with no new clinical results reported.

research PDGF Isoforms Induce and Maintain Anagen Phase of Murine Hair Follicles

136 citations , June 2006 in “Journal of Dermatological Science”

This study found that injecting PDGF-AA and -BB into mouse skin immediately triggered the hair growth cycle's anagen phase, suggesting potential treatment options for certain types of alopecia.

research Conditional Disruption of Hedgehog Signaling Pathway Defines Its Critical Role in Hair Development and Regeneration

194 citations , May 2000 in “Journal of Investigative Dermatology”

This study demonstrated that blocking the Sonic hedgehog signaling pathway in mice led to reversible inhibition of body coat hair morphogenesis, while whisker development was unaffected.

research Genetically Null Mice Reveal a Central Role for Epidermal Growth Factor Receptor in the Differentiation of the Hair Follicle and Normal Hair Development

107 citations , June 1997 in “PubMed”

In this study, disrupting the epidermal growth factor receptor in mice led to abnormal hair and skin development, characterized by disorganized hair follicles and systemic disease, providing a model for understanding EGFR's role in skin biology.

research Effects of Epidermal Growth Factor on the Morphology and Patterns of DNA Synthesis in Isolated Human Hair Follicles

94 citations , February 1994 in “The journal of investigative dermatology/Journal of investigative dermatology”

This study concluded that epidermal growth factor may induce a 'catagen-like' phase in human hair follicles by disrupting normal cellular proliferation and migration patterns.

research Comparison of Epidermal Growth Factor Binding and Receptor Distribution in Normal Human Epidermis and Epidermal Appendages

323 citations , November 1984 in “Journal of Investigative Dermatology”